ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Total Product Sales: $27.6 million for the full year 2025. Net Operating Profit: $1.6 million, an improvement of $3.3 million compared to 2024. Q4 2025 Product Sales: $7.6 million, a decrease of 1.6% compared to Q4 2024. Domestic Sales Growth (Q4 2025): Increased by 8.7% to $7 million. International Sales (Q4 2025): Declined to $600,000, influenced by order timing in Canada. Gross Margin (Q4 2025): 38%, up from 37% in Q4 2024. Gross Margin (Full Year 2025): Increased to 41% from 30% in 2024. Noncash Inventory Write-Downs: $650,000 across Q3 and Q4 2025. Operating Expenses (Q4 2025): $3 million, up from $2.2 million in Q4 2024. Operating Expenses (Full Year 2025): $9.8 million, up from $9.6 million in 2024. Other Expense (Q4 2025): Increased to $2.8 million from $100,000 in Q4 2024. Other Expense (Full Year 2025): Increased to $2.7 million from $500,000 in 2024. Net Loss (Full Year 2025): $1 million, a $1.1 million imp
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve [Yahoo! Finance]Yahoo! Finance
- ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025GlobeNewswire
- ImmuCell (ICCC) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
ICCC
Sec Filings
- 3/4/26 - Form 8-K
- 2/9/26 - Form 8-K
- 2/2/26 - Form 8-K
- ICCC's page on the SEC website